drugset

drugset / Trial / NCT00913341

To Demonstrate the Relative Bioavailability of Alprazolam Tablets, 1 mg

NCT00913341 ↗

Phase 1 Completed 30 enrolled Sandoz

RandomizedCrossoverOpen-labelTreatment

Summary

To demonstrate the relative bioavailability of Alprazolam tablets, 1 mg.

Timeline

Start: 1991-11
Primary completion: 1991-11
Completion: 1991-11

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Alprazolam	Small molecule	1 mg	—

Indications